Canada markets close in 5 hours 27 minutes

Appili Therapeutics Inc. (APLI.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.07500.0000 (0.00%)
As of 12:52PM EDT. Market open.
Full screen
Previous Close0.0750
Open0.0750
Bid0.0750 x N/A
Ask0.0750 x N/A
Day's Range0.0700 - 0.0750
52 Week Range0.0650 - 1.1400
Volume152,500
Avg. Volume177,376
Market Cap9.095M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)-0.4140
Earnings DateJun 29, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.63
  • Baystreet

    Stocks in play: Appili Therapeutics Inc.

    Announced its financial and operational results for the fiscal year ended March 31, 2022. The net loss ...

  • Business Wire

    Appili Therapeutics Reports Fiscal Year 2022 Financial and Operational Results

    HALIFAX, Nova Scotia, June 29, 2022--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational results for the fiscal year ended March 31, 2022, and provided an update on the Company’s strategy for fiscal 2023. All figures are stated in Canadian dollars unless otherwise stated.

  • Business Wire

    Appili Therapeutics Announces Closing of Public Offering of $4,500,000

    HALIFAX, Nova Scotia, May 26, 2022--Appili Therapeutics Inc. (TSX: APLI) (the "Company" or "Appili") announced the closing of its previously announced public offering (the "Offering") of units (the "Units"). The Offering was made pursuant to an agency agreement, as amended, entered into between the Company, Bloom Burton Securities Inc. (the "Lead Agent") and Leede Jones Gable Inc. (collectively with the Lead Agent, the "Agents").